Recommendations from the Global Bioanalysis Consortium Team A8: documentation.

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Regulatory Affairs

Background:

• Bioanalytical documentation is critical for regulatory submissions.
• Current documentation practices vary, impacting review efficiency.
• Harmonization efforts are needed to streamline global regulatory processes.

Purpose of the Study:

• To define essential documentation for small and large molecule bioanalysis.
• To compare current regulatory requirements for bioanalytical data.
• To propose standardized reporting formats for regulatory submissions.

Main Methods:

• Compilation and comparison of current regulatory requirements.
• Review of documentation scope including validation reports, study plans, and raw data.
• Development of a common table of contents for bioanalytical reports.

Main Results:

• A proposed high-level table of contents for method validation and sample analysis reports.
• Suggestions for standardizing the Common Technical Document (CTD) for improved usability.
• Identified areas where prescriptive guidelines are not required, advocating for scientific judgment.

Conclusions:

• Standardized documentation and reporting enhance the review process for bioanalytical data.
• The Common Technical Document (CTD) can be optimized for better usability.
• Good scientific practices should guide documentation in specific circumstances, rather than rigid guidelines.